Neamati HIV-1 Integrase

Mechanism and Inhibitor Design
1. Auflage 2011
ISBN: 978-1-118-01535-3
Verlag: John Wiley & Sons
Format: PDF
Kopierschutz: Adobe DRM (»Systemvoraussetzungen)

E-Book, Englisch, 520 Seiten, E-Book

Reihe: Wiley series in drug discovery and development

This book comprehensively covers the mechanisms of action and inhibitor design for HIV-1 integrase. It serves as a resource for scientists facing challenging drug design issues and researchers in antiviral drug discovery. Despite numerous review articles and isolated book chapters dealing with HIV-1 integrase, there has not been a single source for those working to devise anti-AIDS drugs against this promising target. But this book fills that gap and offers a valuable introduction to the field for the interdisciplinary scientists who will need to work together to design drugs that target HIV-1 integrase.

Autoren/Hrsg.

Neamati, Nouri

Weitere Mitwirkende

Wang, Binghe

Über Autor(innen)

Nouri Neamati, PhD, is an Associate Professor of Pharmacologyand Pharmaceutical Sciences at the University of SouthernCalifornia School of Pharmacy. He is the recipient of numerousawards and has published more than 170 peer-reviewed manuscripts,several book chapters, and patents in the area of drug design anddiscovery. Dr. Neamati is the Editor-in-Chief of Current MolecularPharmacology; an Associate Editor of Current Cancer Drug Targets;and an Editorial Advisory Board member of several journalsincluding Expert Opinion on Drug Discovery, Expert Opinion onInvestigational Drugs, and Hormones & Cancer.